Systolic blood pressure reduction

1 paper1 finding

Humans1

Upstream

1

Clonal hematopoiesis of indeterminate potential

downin humans1

1 study

Clonal hematopoiesis of indeterminate potential impairs systolic blood pressure reduction in humans.
“CHIP carriers exhibited larger left ventricular dimensions, lower ejection fraction, elevated proinflammatory cytokines, smaller reductions in systolic and diastolic blood pressure after medication intensification”
Humansin aTRH after medication intensification
Clonal hematopoiesis in apparent treatment-resistant hypertension, insights from multiple medical centers and community-based cohorts
Nature aging24 Nov 2025

More on Clonal hematopoiesis of indeterminate potential

Latest

6 in 12 months

Brazilian Journal of Physical Therapy16 Sep

Supervised versus non-supervised exercise intervention for blood pressure reduction in patients with hypertension and prehypertension: a systematic review and meta-analysis

Meta-analysis of randomised trialsPrehypertension

Obesity Pillars14 Sep

Effectiveness of dietary, physical activity, and lifestyle interventions on weight and cardiometabolic outcomes in adults with overweight or obesity: an umbrella review of 112 systematic reviews and meta-analyses from 50 countries

Meta-analysis of randomised trialsPhysical activity

EClinicalMedicine6 Sep

Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA

Cohort study of 213,309 peopleGLP-1 receptor agonists

medRxiv2 Sep

A Randomized Controlled Trial Evaluating a Community-Based, Family Network Heart Health Intervention - the SERVE OC Trial: Design, Rationale and Baseline Findings

Preprint: trial protocolInterventions

Diabetes Research and Clinical Practice20 Aug

Efficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis

Meta-analysisGLP-1 receptor agonists

PLOS One13 Aug

Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials

Randomised trial in peopleTirzepatide

Nature Aging25 Nov

Clonal hematopoiesis in apparent treatment-resistant hypertension, insights from multiple medical centers and community-based cohorts

Cohort study in peopleMechanisms

Healthcare30 Aug

Impact of a Multidomain Outdoor Exercise Intervention on Cardiovascular Health and Functional Capacity for Healthy Aging: A Randomized Controlled Trial (ACTIVA-Senior Study)

Randomised trial in 46 peopleResistance training